{
    "eid": "2-s2.0-85103028713",
    "title": "Flattening filter free stereotactic body radiation therapy for lung tumors: outcomes and predictive factors",
    "cover-date": "2021-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Flattening filter free (FFF)",
        "Non-small cell lung cancer (NSCLC)",
        "Oligometastatic/oligoprogressive lung tumor (OLT)",
        "Stereotactic body radiation therapy (SBRT)"
    ],
    "authors": [
        "Thitiporn Jaruthien",
        "Sarin Kitpanit",
        "Danita Kannarunimit",
        "Chonnipa Nantavithya",
        "Anussara Prayongrat",
        "Petch Alisanant",
        "Kitwadee Saksornchai",
        "Napapat Amornwichet",
        "Tassapong Raiyava",
        "Chakkapong Chakkabat",
        "Chawalit Lertbutsayanukul",
        "Chonlakiet Khorprasert",
        "Kanjana Shotelersuk"
    ],
    "citedby-count": 1,
    "ref-count": 33,
    "ref-list": [
        "Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG Oncology/RTOG 0813 Trial",
        "Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study",
        "Stereotactic body radiation therapy for inoperable early stage lung cancer",
        "Review and uses of stereotactic body radiation therapy for oligometastases",
        "Stereotactic radiotherapy for pulmonary oligometastases: a systematic review",
        "Clinical application of flattening filter free beams for extracranial stereotactic radiotherapy",
        "Beam characterization of 10-MV photon beam from medical linear accelerator without flattening filter",
        "Flattening filter-free accelerators: a report from the AAPM therapy emerging technology assessment work group",
        "Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC)",
        "Stereotactic body radiation therapy (SBRT) for lung malignancies: preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute",
        "Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments",
        "Flattening filter free vs. flattened beams for lung stereotactic body radiation therapy",
        "Flattening filter-free technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy: A clinical comparison with the flattening filter technique",
        "Flattening filter free VMAT for a stereotactic, single-dose of 30 Gy to lung lesion in a 15-min treatment slot",
        "Stereotactic body radiation therapy: the report of AAPM Task Group 101",
        "Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer",
        "Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications",
        "Planning target volume D95 and mean dose should be considered for optimal local control for stereotactic ablative radiation therapy",
        "An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancer",
        "Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy",
        "Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group \"stereotactic radiotherapy\"",
        "Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung",
        "Establishing stereotactic body radiotherapy with flattening filter free techniques in the treatment of pulmonary lesions - initial experiences from a single institution",
        "Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments",
        "Effects of flattening filter-free and volumetric-modulated arc therapy delivery on treatment efficiency",
        "Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy",
        "Colorectal histology is associated with an increased risk of local failure in lung metastases treated with stereotactic ablative radiation therapy",
        "Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases",
        "Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer",
        "Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study",
        "Lung metastases treated with stereotactic body radiotherapy: the RSSearch\u00ae patient registry's experience",
        "Clinical results of mean GTV dose optimized robotic-guided stereotactic body radiation therAapy for lung tumors",
        "Prognostic factors for local control and survival for inoperable pulmonary colorectal oligometastases treated with stereotactic body radiotherapy"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": []
}